Biological Dynamics: Mike Aicher, Michael Nall, Michael Russell

Biological Dynamics, a San Diego-based company developing exosome isolation and early disease detection tehcnologies, has appointed Mike Aicher as chief operating officer. Aicher most recently served as executive chairman of Roswell Biotechnologies, and has also been a director at Genetic Technologies, board member at Techcyte, and chairman of the board at CytoBay. He also cofounded and was CEO at National Genetics Institute, now part of Labcorp.

Biological Dynamics also said that Michael Nall is assuming the role of chief commercial officer. Nall most recently served as president, CEO, and a board member at Biocept. Prior to that, he served in senior operational and commercial roles at Clarient, before and after its acquisition by GE Healthcare. Nall currently serves on the boards of Nonigenix Clarity Foundation, and Alacrity, and on the industry relations committee at Moores Cancer Center at the University of California, San Diego Health.

In addition, Michael Russell has replaced Biological Dynamics' cofounder Raj Krishnan as a director. Russell has served as head of finance for several companies including Enevate and MaxLinear. He will serve on the board's audit committee.